Joshua Kamins is a Neurology physician affiliated with University of California, Los Angeles. OpenAlex indexes 20 publications with 2,251 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Medical Plaza Driveway
Suite B200
Los Angeles, CA 900950001
Telephone
310-794-1195Registry record last updated 3 Nov 2016.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lundbeck LLCProgram year202514 payments$10,177openpaymentsdata.cms.gov ↗
- Lundbeck LLCProgram year202411 payments
- Lundbeck LLCProgram year20236 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
96.7%Neuromuscular Blocker96.7%Onabotulinumtoxina100%Part B, office-administered≥33 patientsNervous system
3.2%Serotonin-1b and Serotonin-1d Receptor Agonist0.8%Rizatriptan44%Sumatriptan Succinate20%Almotriptan Malate10%Eletriptan Hbr10%Imitrex10%Naratriptan Hcl8%Part D<11 patientsCalcitonin Gene-related Peptide Receptor Antagonist0.7%Ubrelvy45%Nurtec Odt37%Qulipta18%Part D<11 patients+ 9 more classes in this area
Cardiovascular
0.1%Angiotensin receptor blocker (ARB)0.1%Candesartan Cilexetil100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- New Diagnostic Criteria for Mild Traumatic Brain Injury: Medical-Legal Considerations
Archives of Physical Medicine and Rehabilitation
2025 - The American Congress of Rehabilitation Medicine Diagnostic Criteria for Mild Traumatic Brain Injury
Archives of Physical Medicine and Rehabilitation
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”